The Rivkin Center for Ovarian Cancer & The American Association for Cancer Research Present the

12th Biennial Ovarian Cancer Research Symposium

September 13th-15th, 2018

UNIVERSITY OF WASHINGTON | SEATTLE, WA

12th Biennial Ovarian Cancer Research Symposium Information

The 12th Biennial Ovarian Cancer Research Symposium is presented by the Rivkin Center for Ovarian Cancer and the American Association for Cancer Research. The goal of the Symposium is to bring together clinicians and researchers from across many disciplines and institutions worldwide in order to encourage collaborations toward advancing the field of ovarian cancer research. The conference seeks to enhance the understanding and knowledge of ovarian cancer, especially among junior investigators, discuss the most recent innovations in the field of ovarian cancer research, and address pressing concerns of the leaders in the clinical and research community.

Call for Abstracts

We are now soliciting research and clinical abstracts for the following focus areas for this year’s symposium:

  • Detection and Prevention
  • Genomics and Molecular Mechanisms
  • Tumor Microenvironment & Immunology
  • Novel Therapeutics: Response & Resistance

Abstract Instructions: Abstracts should include the purpose of your study, a brief explanation of the data, and your conclusions (limit 500 words). The deadline for abstract submission is 5pm PST on July 10, 2018.

SUBMIT ABSTRACT

Registration will be open April 2, 2018.

Continuing Medical Education Activity – AMA PRA Category 1 CreditsTM available. Visit www.rivkin.org or call 206-215-6200 for the latest information.

Important Dates


April 2, 2018

Abstract Submissions Open



April 2, 2018

Online Registration Opens



July 10, 2018

Abstract Submissions Close



August 31, 2018

Online Registration Closes (Online registration limited to availability)

CALL FOR ABSTRACTS

The planning committee is now soliciting research and clinical abstracts. Submit by 5PM Pacific Time on Monday, July 10, 2018.

SUBMIT ABSTRACT

Abstracts may be submitted for the following sessions:

  1. Prevention and Early Detection
  2. Genomics and Molecular Mechanisms
  3. Tumor Microenvironment and Immunology
  4. Novel Therapeutics: Response and Resistance
  5. Poster Session

Abstract should include the purpose of your study, a brief explanation of the data, and your conclusions (limit 500 words).

Continuing Medical Education Activity – AMA PRA Category 1 CreditsTM available. Visit www.rivkin.org or call 206-215-6200 for the latest information.

Registration

If you are speaking in a scientific session, you will automatically be registered for the Symposium free of charge. Please do not register yourself online. Registration will open April 2, 2018.

Registration includes entry into scientific sessions from September 13th – 15th and light breakfast, boxed lunch, coffee breaks, and evening receptions on September 13th and 14th. Advanced registration rates are available until August 13th after which regular registration rates will apply. Online registration closes on August 31st, 2018. Onsite registration at regular registration rates may be available on a first come first served basis.

Registration Rates

Advance Registration Until August 13th Regular Registration After August 13th
Physician $400 $450
Researcher $400 $450;
Allied Health $175 $215
Postdoctoral or Clinical Fellow $175 $215
Research Technician $175 $215
Pre-doctoral student (Graduate/Medical/Nursing) $75 $110
Patient/Survivor $0 $0

Continuing Medical Education Activity – AMA PRA Category 1 CreditsTM available.

Visit www.rivkin.org or call 206-215-6200 for the latest information.
For questions, please contact the Rivkin Center office at 206-215-6200, or info@marsharivkin.org.

12th Biennial Ovarian Cancer Research Symposium Planning Committee

The purpose of the Symposium Planning Committee is to develop the scope and goals of the 12th Biennial Ovarian Cancer Research Symposium scheduled for September 13-15th, 2018 in Seattle. The members’ collective expertise will inform the selection of invited speakers, the review of submitted abstracts, and the identification of target audience. The Symposium seeks to enhance the understanding and knowledge of ovarian cancer, especially among junior and young investigators, discuss the most recent innovations in the field of ovarian cancer research, and address the pressing concerns among the leaders of the clinical and research community.

Planning Committee Members:

Frances Balkwill, PhD
(Co-Chair)

Barts Cancer Institute

Mary L. (Nora) Disis, MD
(Co-Chair)

University of Washington

Elizabeth Swisher, MD
(Co-Chair)

University of Washington

Pamela Ohashi, PhD
(Co-Chair)

Princess Margaret Cancer Center

Amy Baran, PhD

American Association for Cancer Research

Kiran Dhillon, PhD

Rivkin Center for Ovarian Cancer

Saul Rivkin, MD

Rivkin Center for Ovarian Cancer

The 12th Biennial Ovarian Cancer Research Symposium was a CME Activity jointly provided by the American Association for Cancer Research and the Rivkin Center for Ovarian Cancer.